A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model. - Wikidata - awgldk - TriplyDB

A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model.

A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model.

http://www.wikidata.org/entity/Q37151518

about

Differential effects of lactacystin on cytokine production in activated Jurkat cells and murine splenocytes The proteasome regulates bacterial CpG DNA-induced signaling pathways in murine macrophages δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens.The effect of bortezomib on expression of inflammatory cytokines and survival in a murine sepsis model induced by cecal ligation and puncture.Regulation of ubiquitin-proteasome and autophagy pathways after acute LPS and epoxomicin administration in mice.Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models The immunoproteasomes regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages.Proteasome protease mediated regulation of cytokine induction and inflammation.A critical role for the inducible proteasomal subunits LMP7 and MECL1 in cytokine production by activated murine splenocytes.LPS-induced formation of immunoproteasomes: TNF-α and nitric oxide production are regulated by altered composition of proteasome-active sites.Targeting the ubiquitin proteasome pathway for the treatment of septic shock in patients.Resveratrol Downregulates Biomarkers of Sepsis via Inhibition of Proteasome's Proteases.Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin-proteasome pathways in cancer cell lines of different organs.Of Mice and Men: Proteasome's Role in LPS-Induced Inflammation and Tolerance.

P2860

Q34024993-A19C4449-FAF3-4BB6-B58E-3D11FFA247FD Q34143900-641B2DAF-0752-4594-ABC7-9873C1A14FF5 Q34646385-27BBE3C0-D2BF-4C29-8A2D-3C7F39136DDE Q34774088-601788B3-B210-4A92-A4E7-6D003D24691C Q35178582-97762038-4FE9-4E94-A6B8-8E029234BB26 Q35505150-D25501F1-4025-403E-91C7-F3D1FFBA96FF Q35539348-2E16F907-53C5-4C2F-867B-3C9EC9ADECE9 Q36301130-9D5489F1-B450-4127-8165-85F68BE035F7 Q36984148-B0B9F6E4-B0B8-4D28-B3F2-6A546261E1EA Q39566694-F3A5D612-4FEB-41B4-9E08-E98AE79B484E Q41810929-489B09D0-5B41-48B2-A22E-84B9BB458B9B Q47310592-50ACA8BA-6030-44F2-B1D9-4374299327AB Q52615465-D4DE01EA-3F30-4F0A-BC19-CEFD4C0B6F87 Q53720678-78FC94C0-8E2C-49D6-9DAB-F2A751F2656A

P2860

A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model.

http://www.wikidata.org/entity/Q37151518

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A combination of proteasome in ...... ality in a septic shock model.

@en

A combination of proteasome in ...... ality in a septic shock model.

@nl

type

label

A combination of proteasome in ...... ality in a septic shock model.

@en

A combination of proteasome in ...... ality in a septic shock model.

@nl

prefLabel

A combination of proteasome in ...... ality in a septic shock model.

@en

A combination of proteasome in ...... ality in a septic shock model.

@nl

P1433

Q37151518-BC2058B6-A63B-464D-9274-48C53F7C29AF

P1476

Q37151518-B923E57D-FE55-40BD-8F98-368AE97838D0

P2093

Q37151518-0171FF7E-5CED-4A7F-8995-EDA4164DE938

Q37151518-023A957B-F621-4201-B2BB-AE4ED5AB73FC

Q37151518-43CF4763-B045-4F61-AA4D-DF02F36AEA2B

Q37151518-51F39AF0-CB1B-44CF-BC15-ECD9B6C6D3BC

Q37151518-6DEF6DB1-8E54-405B-963D-80C7C360003E

Q37151518-AE7E812D-364F-4D2A-BD49-24DBFDFB43E2

Q37151518-BC31111B-EC94-4EB3-A03A-C334F89F78A2

Q37151518-C47720E2-987D-426A-AD0B-018BC35B6632

Q37151518-CEF34736-AFA4-4489-B983-B7ECC43319E6

P2860

Q37151518-079F5CCC-0FD9-4D81-94FC-7A26C0217FEA

Q37151518-116F7F39-FAA5-4E31-82AC-75B881016C9D

Q37151518-1437DFAE-3F79-4673-9DC3-3C6AEC3A3CDC

Q37151518-182F2B68-5291-4E5F-B5AF-6D7F9D1AFCA4

Q37151518-223D4395-6F2F-4864-9980-64470EA1ED50

Q37151518-278E72E5-4D73-40A8-B5C3-C963B112D461

Q37151518-2FC64E6F-2CF7-4042-885F-D6F41E83C4DB

Q37151518-2FE0296D-2613-46AA-BB8A-926638022661

Q37151518-368F2ABB-3D45-483F-BAC3-C34E643527AC

Q37151518-4942D537-7F52-4BCA-A3CA-A7FE0F3815DF

P304

Q37151518-A861F2DF-0317-4AF7-A636-C2AB43B1058D

P31

Q37151518-29E8BA83-29FB-44A8-8705-403E2D5B5771

P356

Q37151518-A10A3490-F3F5-4531-8142-3628EB00EBC7

P433

Q37151518-68B33505-98C0-4D66-A817-6F00EFB3D4EE

P478

Q37151518-0F9C6BAB-DD37-4526-B476-07AA27CACC84

P577

Q37151518-D5C50880-F634-487E-A8F7-575881AC0764

P5875

Q37151518-02A48BBC-C1BC-4688-8725-66F12E9F36D2

P698

Q37151518-63C7B799-B407-40FB-94C5-9348660C7497

P921

Q37151518-13D9C7A8-4C6E-483B-9D99-FD3461FAAE38

Q37151518-F150CF0E-8765-4471-B079-ACF233649904

P932

Q37151518-1187855F-424B-4D24-9150-9E616A1B2299

P356

1753425908096855

P1433

Innate Immunity

P1476

A combination of proteasome in ...... ality in a septic shock model.

@en

P2093

Asaf A Qureshi

http://www.w3.org/2001/XMLSchema#string

Cheryl E Rockwell

http://www.w3.org/2001/XMLSchema#string

Christopher J Papasian

http://www.w3.org/2001/XMLSchema#string

David C Morrison

http://www.w3.org/2001/XMLSchema#string

Julia Reis

http://www.w3.org/2001/XMLSchema#string

Nilofer Qureshi

http://www.w3.org/2001/XMLSchema#string

Rongjie Yang

http://www.w3.org/2001/XMLSchema#string

Stefanie N Vogel

http://www.w3.org/2001/XMLSchema#string

Xiaoyu Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events

A receptor-mediated pathway for cholesterol homeostasis

The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

Intracellular targeting of the proteasome.

The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system.

Taking toll: lipid A mimetics as adjuvants and immunomodulators.

Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide.

P304

319-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1753425908096855

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23275124

http://www.w3.org/2001/XMLSchema#string

P698

18809656

http://www.w3.org/2001/XMLSchema#string

P921

P932

2666041

http://www.w3.org/2001/XMLSchema#string